Details for Patent: 10,617,693
✉ Email this page to a colleague
Which drugs does patent 10,617,693 protect, and when does it expire?
Patent 10,617,693 protects KLISYRI and is included in one NDA.
This patent has fifteen patent family members in thirteen countries.
Summary for Patent: 10,617,693
Title: | Methods of treating and/or preventing actinic keratosis |
Abstract: | The application pertains to methods of treating and/or preventing actinic keratosis, comprising administering a therapeutically effective amount of KX-01, ##STR00001## to a subject in need thereof. |
Inventor(s): | Kwan; Min-Fun Rudolf (Summit, NJ), Lau; Johnson Yiu-Nam (Newport Beach, CA), Kramer; E. Douglas (Stamford, CT), Cutler; David Lawrence (Moorestown, NJ), Fang; Jane (Newport Beach, CA) |
Assignee: | Athenex, Inc. (Buffalo, NY) |
Application Number: | 15/918,100 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,617,693
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TOPICAL TREATMENT OF ACTINIC KERATOSIS OF THE FACE OR SCALP | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,617,693
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018231144 | ⤷ Try a Trial | |||
Brazil | 112019018687 | ⤷ Try a Trial | |||
Canada | 3055938 | ⤷ Try a Trial | |||
China | 110891575 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |